Putrajaya, September 3, 2025 — Malaysia has taken a historic step in healthcare inclusion with the pre-launch of its first-ever National Policy for Rare Diseases, a strategic framework aimed at closing critical gaps in diagnosis, treatment, and support for patients living with rare medical conditions.
Health Minister Datuk Seri Dr. Dzulkefly Ahmad declared that the policy, unveiled on August 27, marks a national commitment to ensuring Malaysians with rare diseases receive the attention and care they deserve. “Though rare diseases affect fewer than 1 in 4,000 individuals, those experiencing them often endure long, uncertain, and isolating journeys to diagnosis and treatment,” he told Bernama. “Only a small fraction of the estimated 6,000 to 8,000 rare conditions worldwide have approved treatments—this is why we must act.”
The policy is anchored in five foundational pillars designed to enhance inclusion and effectiveness: early detection, fairer access to treatment, strengthened research and innovation, development of clinical expertise, and the creation of a national rare disease database. Dr. Dzulkefly emphasised that beyond statistics are real children, parents, and families whose resilience the policy seeks to support. “To them I say: You matter, and you will not be forgotten,” he said.
Globally, the World Health Organization defines rare diseases as typically chronic, serious, and often life-threatening conditions affecting a small part of the population. The majority of these—estimated between 6,000 and 8,000—stem largely from genetic factors.
